문합기 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

Global Anastomosis devices market was valued at USD 3.60 billion in 2024 and is projected to exhibit steady growth over the forecast period, with a compound annual growth rate (CAGR) of 5.28% through 2030.

The medical devices sector has experienced significant technological advancements in recent years, with notable progress in the development of anastomosis devices. These devices are essential in surgical procedures, enabling the connection of two blood vessels or hollow organs-such as the intestines or ureters-to restore normal physiological function. Anastomosis devices have become indispensable in a variety of surgical specialties, including cardiovascular, gastrointestinal, and urological procedures.

Market growth has been consistently strong, driven by factors such as the increasing prevalence of chronic diseases, an aging global population, and advancements in surgical techniques. These devices are critical in procedures such as bypass grafting, bowel resections, and organ transplantation, all of which are becoming more frequent.

Key Market Drivers

Rising Number of Surgical Procedures

The increasing volume of surgical procedures globally is a primary factor fueling the growth of the anastomosis devices market. It is estimated that between 220 and 344 million surgeries are performed worldwide annually, with high-frequency operations such as cataract removals, cesarean deliveries, and orthopedic joint replacements accounting for a significant portion. Despite this, disparities in access to safe, timely, and affordable surgical care persist-particularly in low- and middle-income countries-posing a barrier to healthcare equity and system development.

Anastomosis devices are integral in surgeries requiring the connection of blood vessels, gastrointestinal structures, or other tubular systems. As the global demand for surgical interventions increases, so does the need for reliable, efficient, and minimally invasive anastomosis solutions.

Each year, an estimated two million patients undergo open-heart surgery to treat conditions such as coronary artery disease, valvular abnormalities, and congenital heart defects. These complex procedures often require precise vascular connections, driving the demand for high-performance anastomosis devices.

Furthermore, the global rise in chronic diseases-such as cardiovascular disorders, cancer, gastrointestinal conditions, and obesity-has led to a growing need for surgical interventions including CABG, colorectal surgery, and bariatric procedures. These often involve anastomosis and underscore the increasing preference for advanced devices that reduce operation times, minimize complications, and enhance patient outcomes. This sustained demand continues to support market growth.

Key Market Challenges

Regulatory Complexity

A major challenge for the anastomosis devices market is navigating stringent regulatory approval processes. Authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce rigorous standards regarding the safety and efficacy of medical devices. Compliance with these requirements can be both time-intensive and costly, often resulting in delays to product launches and increased development expenditures for manufacturers.

Key Market Trends

Technological Innovation

Technological advancements are playing a transformative role in the anastomosis devices market, significantly enhancing surgical precision and patient outcomes. The field has witnessed major innovations that have simplified procedures and improved recovery times.

The adoption of minimally invasive surgical techniques, including robotic-assisted and laparoscopic systems, has improved the accuracy and reduced the invasiveness of complex anastomosis procedures. High-resolution visualization technologies-such as 3D imaging, augmented reality, and intraoperative imaging systems-enable surgeons to perform more precise operations with real-time feedback.

Innovations in biomaterials and tissue engineering are also reshaping the market. New materials that promote tissue regeneration and healing-such as bio-absorbable staples and tissue adhesives-are reducing post-operative risks. Advanced surgical staplers now feature adjustable staple heights, tissue-sensing capabilities, and real-time feedback systems to ensure optimal performance.

Electrosurgical devices are becoming increasingly popular for their precision and ability to minimize bleeding during tissue dissection and coagulation, leading to reduced post-surgical complications.

Key Market Players

• Medtronic plc
• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• Dextera Surgical Inc.
• Vitalitec Internaional Inc.
• Synovis Micro Companies Alliance, Inc.
• Ethicon US, LLC
• Peters Surgical SASU

Report Scope:

In this report, the Global Anastomosis Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anastomosis Devices Market, By Product:

• Disposable
• Reusable

Anastomosis Devices Market, By Application:

• Cardiovascular Surgery
• Gastrointestinal Surgery
• Others

Anastomosis Devices Market, By End-Use:

• Hospitals
• Ambulatory Care Centres & Clinics

Anastomosis Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anastomosis Devices Market.

Available Customizations:

Global Anastomosis Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Anastomosis Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Disposable, Reusable)
  • 5.2.2. By Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others)
  • 5.2.3. By End-Use (Hospitals, Ambulatory Care Centers & Clinics)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Anastomosis Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anastomosis Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Anastomosis Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Anastomosis Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Anastomosis Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anastomosis Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. United Kingdom Anastomosis Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. Italy Anastomosis Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. France Anastomosis Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Anastomosis Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia-Pacific Anastomosis Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Anastomosis Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Anastomosis Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Anastomosis Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Anastomosis Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Anastomosis Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. South America Anastomosis Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Anastomosis Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. Argentina Anastomosis Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. Colombia Anastomosis Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. Middle East and Africa Anastomosis Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Anastomosis Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Saudi Arabia Anastomosis Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. UAE Anastomosis Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Anastomosis Devices Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Medtronic plc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. LivaNova PLC
• 14.3. MAQUET Holding B.V. & Co. KG.
• 14.4. Dextera Surgical Inc.
• 14.5. Vitalitec Internaional Inc.
• 14.6. Synovis Micro Companies Alliance, Inc.
• 14.7. Ethicon US, LLC
• 14.8. Peters Surgical SASU

15. Strategic Recommendations

16. About Us & Disclaimer